BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1432161)

  • 1. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents.
    Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA
    J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimyosin imaging in cardiac transplant rejection.
    Johnson LL; Cannon PJ
    Circulation; 1991 Sep; 84(3 Suppl):I273-9. PubMed ID: 1884496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.
    Frist W; Yasuda T; Segall G; Khaw BA; Strauss HW; Gold H; Stinson E; Oyer P; Baldwin J; Billingham M
    Circulation; 1987 Nov; 76(5 Pt 2):V81-5. PubMed ID: 3311460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
    Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
    J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model.
    Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ
    J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection.
    Breuer M; Schütz A; Engelhardt M; Hammer C; Kemkes BM
    Angiology; 1999 Jul; 50(7):563-71. PubMed ID: 10431996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab.
    Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ
    J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoscintigraphy with 111In antimyosin Fab.
    Morguet AJ; Munz DL; Kreuzer H; Emrich D
    Nucl Med Commun; 1990 Nov; 11(11):727-35. PubMed ID: 2277688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal Fab antimyosin in cardiac imaging.
    Johnson LL
    Clin Cardiol; 1992 Mar; 15(3):145-53. PubMed ID: 1551261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts.
    Isobe M; Haber E; Khaw BA
    Circulation; 1991 Sep; 84(3):1246-55. PubMed ID: 1884451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection.
    De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A
    J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of cardiac rejection by simultaneous administration of 123I-antimyosin and 111In-anti MHC class II antibodies.
    Isobe M; Sekiguchi M
    Acta Cardiol; 1996; 51(6):515-20. PubMed ID: 9124020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
    Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
    J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of indium-111-labeled antimyosin monoclonal antibody in murine experimental viral myocarditis.
    Yamada T; Matsumori A; Watanabe Y; Tamaki N; Yonekura Y; Endo K; Konishi J; Kawai C
    J Am Coll Cardiol; 1990 Nov; 16(5):1280-6. PubMed ID: 2172346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo targeting of acute myocardial infarction with negative-charge, polymer-modified antimyosin antibody: use of different cross-linkers.
    Narula J; Torchilin VP; Petrov A; Khaw S; Trubetskoy VS; O'Donnell SM; Nossiff ND; Khaw BA
    J Nucl Cardiol; 1995; 2(1):26-34. PubMed ID: 9420759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?
    Ueda K; Takeda K; LaFrance ND; Solez K; Baumgartner WA; Reitz BA; Herskowitz A
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):778-81. PubMed ID: 2831646
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin.
    Nishimura T; Sada M; Sasaki H; Yutani C; Hayashi M; Amemiya H; Fujita T; Akutsu T; Manabe H
    Eur J Nucl Med; 1987; 13(7):343-7. PubMed ID: 3322830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-antimyosin antibody imaging for the detection of acute myocardial infarction in human beings.
    Senior R; Bhattacharya S; Manspeaker P; Liu XJ; Leppo JA; Lahiri A
    Am Heart J; 1993 Sep; 126(3 Pt 1):536-42. PubMed ID: 8362706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model.
    Zalutsky MR; Garg PK; Johnson SH; Utsunomiya H; Coleman RE
    J Nucl Med; 1992 Apr; 33(4):575-80. PubMed ID: 1552343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody.
    Narula J; Nicol PD; Southern JF; Pieri P; O'Donnell SM; Guererro JL; Nossiff ND; Newell JB; Strauss HW; Khaw BA
    J Nucl Med; 1994 Jun; 35(6):1076-85. PubMed ID: 8195873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.